Navam Capital

Vayudh's aim is to create next-generation nanodrones and swarming technologies for modern defense and security applications.

GalaxEye provides satellite-based imaging services that leverage advanced space technology to deliver high-frequency data for earth observation. By utilizing multi-sensor imaging satellites, the company offers detailed spatial and temporal resolution, allowing businesses in both government and commercial sectors to enhance decision-making and operational efficiency.

Alyssum Therapeutics is a biotechnology company dedicated to developing advanced immunotherapies aimed at modulating B cells for cancer treatment. Utilizing supramolecular technology, the company designs innovative therapeutic agents that target tumors and enhance the immune response against cancer. Its portfolio includes treatments and antibody drugs specifically formulated for various cancers, such as lung, testicular, colorectal, and childhood cancers. By focusing on the interaction between the immune system and cancer cells, Alyssum Therapeutics aims to empower oncologists to effectively combat cancer and improve patient outcomes.

Aereo, formerly known as Aarav Unmanned Systems, is a leading drone manufacturing and solutions company based in Bangalore, India, founded in 2013 at IIT Kanpur. The company specializes in providing end-to-end drone technology solutions tailored for various sectors, including urban and rural development, agriculture, mining, construction, irrigation, forest conservation, renewable energy, and infrastructure development. Aereo's drones are designed to enhance productivity and data quality, offering advanced business intelligence that aids in critical decision-making. The firm has achieved significant milestones, including mapping over 34,000 villages and impacting the lives of over 45 million individuals. Notably, Aereo was the first to launch India’s DGCA-certified survey-grade PPK drone. Their technology includes a proprietary 3-dimensional web-GIS that allows for 360-degree visibility and efficient image processing, thereby supporting enterprise stakeholders in managing data more effectively.

Morphing Machines is on a mission to create an exciting new range of silicon-centric solutions for compute-intensive applications. Leveraging the path-breaking patent-pending REDEFINE Reconfigurable Massively Parallel Processor SoC platform technology, a variety of high-performance silicon solutions for various application domains have been developed at Morphing Machines in the areas of cryptography, data security, avionics, high-definition image and video processing, numerical computation, neural networks and deep learning, and other areas. REDEFINE based solutions deliver a unique combination of high performance and flexibility not available from other technologies offered by global players. REDEFINE technology enables ASIC-like high performance at an affordable NRE cost for a much wider range of compute-intensive applications than has ever been possible before. Advanced compiler toolchain and runtime software support is an integral part of the REDEFINE offerings.

TechEagle Innovations is a drone logistics company focused on transforming last-mile delivery with innovative, temperature-controlled solutions tailored for healthcare, e-commerce, and essential goods. The company designs advanced hybrid drones and autonomous fleet management systems, enabling efficient and reliable delivery of critical items such as medicines, vaccines, and perishables. TechEagle's proprietary technology includes hybrid e-VTOL drones capable of long-range operations and adaptable payloads, ensuring precision in various environments. With regulatory approvals for operations in restricted airspaces, TechEagle is establishing itself as a leader in the drone logistics industry. The company’s ecosystem encompasses autonomous drones, cloud-based fleet management software, and Unmanned Aircraft System Traffic Management systems, enhancing supply chain operations across multiple sectors, including government and maritime. Headquartered in India, TechEagle has executed significant projects with various organizations, showcasing its ability to operate effectively in both urban and remote areas. Recognized for its innovation, TechEagle is set to redefine logistics through its drone delivery networks on a global scale.

Fasal is an agri-tech platform developed by Wolkus Technology Solutions that leverages artificial intelligence to enhance agricultural practices. The platform records various growing conditions on farms and utilizes data science to generate on-farm predictions. It delivers insights to users on any device, including iOS, Android, tablets, and web platforms. By providing real-time agronomic recommendations based on on-farm and micro-climate data collected through agnostic sensors, Fasal helps farmers optimize their resource usage, leading to cost savings in water, energy, fertilizers, and pesticides. Additionally, the platform offers detailed intelligence tailored to specific crops and growth stages, equipping farmers with vital information for predictive weather, pest management, and strategies to improve harvest yields.

Ather Energy is an Indian manufacturer of electric scooters and a charging network known as AtherGrid, dedicated to creating a comprehensive ecosystem for electric vehicles in the country. The company's flagship product, the Ather 450X, is celebrated for its powerful performance, extended range, and innovative smart features, including a touchscreen dashboard and connectivity through a mobile app. Ather also offers the Ather 450 Plus, which shares many of the advanced features of the 450X while being more affordable. Both models are equipped with lithium-ion battery packs and a digital battery management system, providing users with essential functions such as navigation, ride statistics, and access to charging points, thereby promoting a cleaner and safer mode of transportation. Ather Energy emphasizes indigenous design and local manufacturing in its operations.

Tvasta is focused on advancing manufacturing and automation technologies, particularly in the field of 3D printing. The company designs 3D printers capable of utilizing materials such as concrete, metals, polymers, and ceramics. By innovating in this area, Tvasta aims to transform product development and delivery processes across various industries, including construction, automotive, aerospace, and medical. The company is committed to enhancing human productivity and personalization, offering a comprehensive experience through its technology systems. With a strong emphasis on research and development, Tvasta aspires to lead in creating groundbreaking products that will redefine industry standards.

Alyssum Therapeutics is a biotechnology company dedicated to developing advanced immunotherapies aimed at modulating B cells for cancer treatment. Utilizing supramolecular technology, the company designs innovative therapeutic agents that target tumors and enhance the immune response against cancer. Its portfolio includes treatments and antibody drugs specifically formulated for various cancers, such as lung, testicular, colorectal, and childhood cancers. By focusing on the interaction between the immune system and cancer cells, Alyssum Therapeutics aims to empower oncologists to effectively combat cancer and improve patient outcomes.

Agnikul Cosmos Private Limited, founded in 2017 and based in Chennai, India, is a space technology startup specializing in the design, manufacture, testing, and launch of orbital-class rockets tailored for micro and nanosatellites. The company operates from the National Center for Combustion R&D at IIT-Madras, where a diverse team of rocket scientists, engineers, ex-bankers, and space lawyers collaborates to advance their capabilities. Agnikul's launch vehicles are mobile and can be deployed from various launch ports, utilizing kerosene as fuel. They are engineered to reach both low and high-inclination orbits, providing businesses with on-demand access to space at competitive prices.

Orangewood Labs Inc., based in San Francisco, California, specializes in manufacturing and distributing customized furniture while also focusing on the development of robotic arms designed for small businesses. The company aims to democratize access to robotics by providing safe, user-friendly, and cost-effective solutions that address contemporary manufacturing challenges. Through its innovative approach, Orangewood Labs seeks to empower small enterprises with advanced technology that enhances productivity and efficiency in the furniture industry.

Invictus Oncology Pvt. Ltd. is a biopharmaceutical company based in New Delhi, India, established in 2011. The company focuses on developing innovative therapeutics for cancer treatment, aiming to improve the lives of cancer patients. It specializes in supramolecular therapeutics, which are designed to serve as next-generation treatments targeting various cancer types, including lung, testicular, colorectal, and childhood cancers. Invictus Oncology emphasizes the creation of the first anti-cancer drug from India, utilizing advanced technology to design treatments that specifically target tumors and enhance the immune response. This approach enables oncologists to effectively combat cancer cells by activating the patient's immune system.

Vyome Therapeutics is a biopharmaceutical company focused on developing novel drugs to combat antibiotic-resistant acne and other opportunistic pathogens. The company offers a range of products, including VB 1953, its lead molecule aimed at addressing the unmet needs in the drug-resistant acne market, as well as DARTS, which prevents resistance development in acne and other pathogens. Additionally, Vyome's portfolio includes various anti-dandruff treatments, such as VB 001, an anti-dandruff scalp care product, VB 2421, an anti-dandruff hair gel, VB 3222, a wash-off shampoo, and VB 7731, a Ketoconazole emulsion gel. Established in 2010 and headquartered in Princeton, New Jersey, Vyome Therapeutics is committed to innovation through its risk-mitigated development platform and state-of-the-art research infrastructure. The company aims to provide effective solutions for refractory skin conditions, enhancing treatment options for patients and healthcare professionals.

Invictus Oncology Pvt. Ltd. is a biopharmaceutical company based in New Delhi, India, established in 2011. The company focuses on developing innovative therapeutics for cancer treatment, aiming to improve the lives of cancer patients. It specializes in supramolecular therapeutics, which are designed to serve as next-generation treatments targeting various cancer types, including lung, testicular, colorectal, and childhood cancers. Invictus Oncology emphasizes the creation of the first anti-cancer drug from India, utilizing advanced technology to design treatments that specifically target tumors and enhance the immune response. This approach enables oncologists to effectively combat cancer cells by activating the patient's immune system.

Vyome Therapeutics is a biopharmaceutical company focused on developing novel drugs to combat antibiotic-resistant acne and other opportunistic pathogens. The company offers a range of products, including VB 1953, its lead molecule aimed at addressing the unmet needs in the drug-resistant acne market, as well as DARTS, which prevents resistance development in acne and other pathogens. Additionally, Vyome's portfolio includes various anti-dandruff treatments, such as VB 001, an anti-dandruff scalp care product, VB 2421, an anti-dandruff hair gel, VB 3222, a wash-off shampoo, and VB 7731, a Ketoconazole emulsion gel. Established in 2010 and headquartered in Princeton, New Jersey, Vyome Therapeutics is committed to innovation through its risk-mitigated development platform and state-of-the-art research infrastructure. The company aims to provide effective solutions for refractory skin conditions, enhancing treatment options for patients and healthcare professionals.

Vyome Therapeutics is a biopharmaceutical company focused on developing novel drugs to combat antibiotic-resistant acne and other opportunistic pathogens. The company offers a range of products, including VB 1953, its lead molecule aimed at addressing the unmet needs in the drug-resistant acne market, as well as DARTS, which prevents resistance development in acne and other pathogens. Additionally, Vyome's portfolio includes various anti-dandruff treatments, such as VB 001, an anti-dandruff scalp care product, VB 2421, an anti-dandruff hair gel, VB 3222, a wash-off shampoo, and VB 7731, a Ketoconazole emulsion gel. Established in 2010 and headquartered in Princeton, New Jersey, Vyome Therapeutics is committed to innovation through its risk-mitigated development platform and state-of-the-art research infrastructure. The company aims to provide effective solutions for refractory skin conditions, enhancing treatment options for patients and healthcare professionals.

EnNatura Technology Ventures is a clean materials company based in New Delhi, India, founded in 2006. The company specializes in developing specialty chemicals derived from renewable sources, focusing on designing polymers that minimize hydrocarbon consumption. Additionally, it offers a resin platform tailored for the printing ink industry, along with eco-friendly printing inks, thereby contributing to sustainable practices within the sector.

Frinks AI is an AI Software Development firm offering Effective, Efficient and Reliable Quality Control.